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ABSTRACT 
Objective The cerebroplacental ratio (CPR) has been proposed for the routine 
surveillance of pregnancies with suspected fetal growth restriction (FGR), but the 
predictive performance of this test is unclear. The aim of this study was to 
determine the accuracy of the CPR for predicting adverse perinatal and 
neurodevelopmental outcomes in suspected FGR.    
Methods PubMed, EMBASE, CINAHL, and Lilacs (all from inception to July 31, 
2017) were searched for cohort or cross-sectional studies that reported on the 
accuracy of the CPR for predicting adverse perinatal and/or neurodevelopmental 
outcomes in singleton pregnancies with antenatally suspected FGR based on 
sonographic parameters. Summary receiver operating characteristic (ROC) 
curves, pooled sensitivities and specificities, and summary likelihood ratios (LRs) 
were generated.  
Results Twenty-two studies (4301 women) met the inclusion criteria. Summary 
ROC curves showed that the best predictive accuracy of the CPR was for 
perinatal death and the worst was for neonatal acidosis, with areas under the 
summary ROC curves of 0.83 and 0.57, respectively. The predictive accuracy of 
the CPR was moderate-to-high for perinatal death (pooled sensitivity and 
specificity of 93% and 76%, respectively, and summary positive and negative 
LRs of 3.9 and 0.09, respectively), and low for composite of adverse perinatal 
outcomes, cesarean section for non-reassuring fetal status, Apgar <7 at 5 
minutes, admission to the neonatal intensive care unit, neonatal acidosis, and 
neonatal morbidities with summary positive and negative LRs ranging from 1.1-
2.5, and 0.3-0.9, respectively. An abnormal CPR result had moderate accuracy 
for predicting small for gestational age at birth (summary positive LR of 7.4). The 
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CPR had a higher predictive accuracy in pregnancies with suspected early-onset 
FGR. No study provided data for assessing the predictive accuracy of the CPR 
for adverse neurodevelopmental outcomes.  
Conclusion The CPR appears to be useful in predicting perinatal death in 
pregnancies with suspected FGR. Nevertheless, before incorporating the CPR 
into the routine clinical management of suspected FGR, randomized controlled 
trials should assess whether the use of the CPR reduces perinatal death or other 
adverse perinatal outcomes.
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INTRODUCTION
Fetal growth restriction (FGR) is a major clinical and public health challenge 
around the world1,2. Small for gestational age (SGA) at birth, based on different 
cut-off values, is a commonly used proxy measure of FGR3. FGR is associated 
with an increased risk of short- and long-term morbidity and mortality, as well as 
impaired neurological and cognitive development4-11. 
Suspected FGR is defined in the antenatal period by sonographic 
estimation of fetal anthropometric measures using a wide range of seldom 
validated definitions and cut-off values12-16. The clinical management of 
suspected FGR is challenging and no consensus exists for the best way to 
monitor fetal well-being in these pregnancies; consequently, clinical practice 
varies considerably around the world17-19. The use of umbilical artery (UA) 
Doppler velocimetry in high-risk pregnancies, including those with suspected 
FGR, has been shown to be associated with a significant reduction in perinatal 
mortality and fewer cesarean deliveries and inductions of labour20.   
In 1987, Arbeille et al.21 reported that the cerebroplacental ratio (CPR), a 
measure of cerebral centralization of fetal blood flow, appeared to be superior to 
either the middle cerebral artery (MCA) or UA Doppler indices alone in predicting 
SGA among women with gestational hypertension. The CPR is calculated by 
dividing the Doppler indices (pulsatility index [PI], resistance index [RI], or 
systolic/diastolic ratio [S/D]) of the MCA by the UA. Physiologically, the CPR 
represents the interaction of alterations in blood flow to the brain as manifest by 
increased diastolic flow as a result of cerebrovascular dilatation due to hypoxia 
and increased placental resistance, leading to decreased diastolic flow in the 
UA22. Integrating the CPR into the clinical management of suspected FGR has 
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recently been proposed22-27, but the test’s ability to predict adverse perinatal 
outcomes in this entity has been questionned28,29. Hence, we carried out a 
systematic review and meta-analysis to assess the accuracy of the CPR to 
predict adverse perinatal and neurodevelopmental outcomes in antenatally 
suspected FGR.  
METHODS
The systematic review was conducted following a prospectively prepared 
protocol and reported in accordance with recommended methods for systematic 
reviews of diagnostic test accuracy30,31. The protocol was registered with 
PROSPERO on March 2016 (CRD42016036488; available from: 
http://www.crd.york.ac.uk/PROSPERO/display_record.php?ID=CRD4201603648
8).   
Literature search  
We searched PubMed, EMBASE, CINAHL, and Lilacs (all from inception to July 
31, 2017) using a combination of keywords and text words related to 
cerebroplacental ratio and fetal growth restriction without language restrictions 
(Appendix S1).  
Eligibility criteria 
We included cohort or cross-sectional studies that reported on the accuracy of 
the CPR for predicting adverse perinatal and/or neurodevelopmental outcomes 
in singleton pregnancies with antenatally suspected FGR based on sonographic 
parameters, and provided the necessary information to generate 2x2 tables. 
Studies were excluded if they: (1) assessed retrospectively the predictive 
accuracy of the CPR in infants categorized as SGA or FGR based on postnatal 
parameters such as birthweight or other anthropometric measures, and/or 
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placental histopathology; (2) assessed the CPR in a mix of high-risk pregnancies 
but did not report results separately for pregnancies with suspected FGR; (3) 
assessed the CPR in the general population as a screening tool; (4) were case-
control studies without complete information for cases with suspected FGR, case 
series or reports, editorials, comments, reviews, or letters without original data; 
(5) reported data for the CPR only as mean or median values; (6) did not publish 
accuracy test estimates or sufficient information to calculate them could not be 
retrieved.  
One reviewer (A.C.-A.) screened titles and abstracts of all identified 
citations and selected potentially eligible studies. Then, these studies were 
retrieved and assessed by the same reviewer for inclusion and data extraction, 
and a 10% sample of the papers was examined by a second independent 
reviewer (J.V.).  Disagreements were resolved through consensus. In cases of 
duplicate publication, we included only the most recent or complete version.  
Reference standard outcomes 
The reference standard outcomes included the following: perinatal death; any 
composite of adverse perinatal outcomes (as defined in the original study and 
regardless of its individual components); cesarean delivery for fetal distress/non-
reassuring fetal status; Apgar <7 at 5 minutes; admission to the neonatal 
intensive care unit (NICU); neonatal acidosis; neonatal brain lesions; neonatal 
morbidities other than brain lesions; use of mechanical ventilation; SGA at birth 
(birthweight <10th, <5th or <3rd perpercentile or <2 standard deviations of mean 
adjusted for gestational age and based on local population values), and adverse 
neurodevelopmental outcomes (suspected or diagnosed developmental delay, 
cerebral palsy, intellectual disabilities, vision impairment, hearing loss, cognitive 
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and behavioral impairments, and motor, communication and learning disorders at 
any age in childhood).  
Assessment of risk of bias 
The risk of bias in each included study was evaluated by at least one investigator 
using a modified version of the QUADAS (Quality Assessment of Diagnostic 
Accuracy Studies)-2 tool32. The following domains were assessed: study design, 
description of the test, selection of test cut-off value, blinding of clinicians to the 
CPR results, inclusion of participants recruited into the study in the analysis, and 
use of interventions aimed to prevent adverse perinatal outcomes based on the 
CPR results. Each domain was scored as “low risk”, “high risk”, or “unclear risk” 
of bias (Appendix S2). We did not calculate a summary score estimating the 
overall quality of each study because of the well-known problems associated with 
such scores33.  
Data extraction 
Data were extracted from each article using a specially designed form for 
capturing information on study characteristics (authors, setting, year of 
publication, method of recruiting women, design, prospective or retrospective 
data collection, blinding of test results, flow diagram, completeness of follow-up 
and reporting of withdrawals, and use of interventions after performing the test), 
patient characteristics (inclusion and exclusion criteria, sample size, and 
demographic characteristics), how the test was carried out (gestational age at 
testing, frequency of test, method of performance of test, type of Doppler and 
route, site of measurement, plane in which images were obtained, Doppler index 
used [PI, RI, or S/D], cut-off value used, and interval from Doppler examination to 
delivery), and reference standard outcomes assessed and their prevalences.  
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For each study and for all cut-off values defining an abnormal CPR result, 
we extracted the number of true positive, false positive, true negative, and false 
negative test results. When predictive accuracy data were not available, we 
recalculated them from the reported results including scatterplot and bar graphs. 
The corresponding authors of primary studies were contacted to obtain additional 
information on methods used and/or unpublished relevant data. Only three 
authors supplied additional data.  
Data synthesis 
Data extracted from each study were used to construct 2x2 contingency tables. 
When any single cell in these tables contained a zero, we added 0.5 to each cell 
to enable calculation of predictive values34. Sensitivity and specificity with 95% 
confidence intervals (CIs) were calculated separately for all Doppler indices and 
cut-off values used, and reference standard outcomes reported. Then, we 
constructed summary receiver-operating characteristic (ROC) curves for each 
predefined reference standard outcome using the hierarchal summary ROC 
model, regardless of Doppler indices and cut-off values used to define 
abnormality35. Variation in cut-off values across studies is taken into account by 
using this model. Pooled estimates and 95% Cis of sensitivity and specificity 
were generated using random-effects bivariate meta-regression models36. For 
studies that reported results for more than one Doppler index and/or cut-off 
value, we selected the most commonly used. We also calculated area under the 
summary ROC curves with their corresponding 95% CIs, which allowed for 
comparison of the predictive accuracy of the CPR for different outcomes37. 
Thereafter, summary likelihood ratios (LRs) with 95% CIs were calculated 
from the pooled sensitivities and specificities38. A guide for the interpretation of 
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LRs suggests that LRs >10 for a positive test result and LRs <0.1 for a negative 
test result generate large changes from pretest to post-test probabilities of 
disease; LRs of 5 to 10 and 0.1 to 0.2 generate moderate changes in probability; 
LRs of 2 to 5 and 0.2 to 0.5 generate small (but sometimes important) changes in 
probability; and LRs of 1 to 2 and 0.5 to 1 generate minimal (and rarely 
important) changes in probability39. Finally, we planned to calculate the post-test 
probabilities of the most important reference standard outcomes by combining 
summary LRs obtained from meta-analyses for positive and negative test results 
and a global prevalence (pretest probability) of these reference standard 
outcomes across the studies39. 
Prespecified subgroup analyses were carried out to assess the predictive 
accuracy of the CPR for any composite of adverse perinatal outcomes according 
to gestational age (GA) at diagnosis or delivery (early-onset [<32 or <34 weeks] 
and late-onset [≥32 or ≥34 weeks], as defined by the authors), definition of 
abnormal CPR result (MCA-PI/UA-PI ≤1.08, MCA-PI/UA-PI <5th percentile, and 
MCA-RI/UA-RI <1 or <1.05), interval from CPR to delivery (≤7 and >7 days), and 
definition of suspected FGR used (estimated fetal weight [EFW] <10th percentile 
for GA and EFW <10th percentile for GA and abnormal UA Doppler). In addition, 
a post-hoc subgroup analysis according to the use or non-use of the CPR results 
for managing pregnancies with suspected FGR was performed. We also 
assessed the effect of risk of bias of the included studies on the predictive 
accuracy of the CPR by performing a sensitivity analysis, including only studies 
with a low risk of bias in at least five of the six domains evaluated.   
As it is common in diagnostic accuracy studies, we anticipated that there 
would be substantial between-study variation in reported pairs of sensitivity and 
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specificity values. As forest plots, which display both sensitivity and specificity, 
depict estimates with associated CIs it is possible to discern the presence of high 
levels of heterogeneity where there is little overlap in the CIs from different 
studies. In order to formally investigate potential sources of heterogeneity, we 
used subgroup analysis and meta-regression by including covariates defined a 
priori (Doppler indices and cut-off values used, definition of suspected FGR 
used, GA at diagnosis or delivery, interval from CPR to delivery, and study’s risk 
of bias) in the bivariate model, which enabled us to assess the effect of various 
factors on the predictive accuracy of the CPR40,41. If there were at least 10 
studies included in a meta-analysis, we assessed publication and related biases 
by examining the symmetry of the funnel plots with the Deeks’ test42. A value of 
P <0.1 for the slope coefficient indicated significant asymmetry of the funnel plot. 
We used SAS version 9.2 (SAS Institute Inc, Cary, NC) for the analyses 
and Review Manager 5.3.5 (The Nordic Cochrane Centre, Copenhagen, 
Denmark) to generate forest plots and summary ROC curves. 
RESULTS
Selection, characteristics and quality of studies
Of 1191 citations initially identified, 22 studies43-64 including a total of 4301 
women/fetuses met the inclusion criteria (Figure 1). Two studies were performed 
using the same cohort60,61, one reporting results for all cases of suspected FGR60
and the other for cases of suspected early-onset FGR61. We included results of 
this last study only in the subgroup analysis according to GA at diagnosis or 
delivery.  
The main characteristics of the included studies are displayed in Table 1. 
All studies but two44,52 were performed in European or North American countries. 
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The sample size ranged from 2948 to 88156 (median, 159). The definitions of 
suspected FGR used in the studies were as follows: EFW <10th percentile for 
GA (11 studies)44,45,47,50,54,56-59,62,64, EFW <10th percentile for GA and/or 
abdominal circumference (AC) <5th percentile (two studies)60,61, EFW <10th 
percentile for GA and abnormal UA Doppler indices (two studies)53,63, AC <5th 
percentile for GA and abnormal UA Doppler indices (two studies)46,49, AC <10th 
percentile for GA (one study)43, AC <10th percentile for GA on at least two 
consecutive measurements, two weeks apart (one study)55, EFW <10th 
percentile for GA with growth rate slower than normal and abnormal UA Doppler 
indices (one study)48, EFW or AC <10th percentile for GA and abnormal UA 
Doppler indices (one study)52, and EFW below the GA-adjusted mean value 
minus 2 SD (2.3rd percentile), or a fall of ≥10% weight deviation from the mean 
weight between two ultrasound examinations (one study)51. Ten studies reported 
results for suspected late-onset FGR47,50,51,54,56-59,62,63, four for suspected early-
onset FGR47,56,58,61, and 13 for suspected FGR at all GAs43-49,52,53,55,56,58,60.
The most common definitions of an abnormal CPR result were MCA-
PI/UA-PI ≤1.08 (eight studies43,47,51-53,56,60,61) and MCA-PI/UA-PI <5th percentile 
for GA (six studies47,50,54,56,58,62). The mean or median interval between the CPR 
and delivery was <48 hours in five studies46,48,50,51,62, <7 days in six 
studies49,53,56,57,59,64, 7 to 14 days in three studies44,47,58, >14 days in five 
studies45,54,55,60,61, and unreported in three studies43,52,63. Most studies (N=16) 
used the last CPR result before delivery in analyses44,46-55,57-59,62,64. Sixteen 
studies reported that the CPR results were not used to manage the 
pregnancies43-45,47,48,50-53,56,58-63, one reported that the CPR results were used to 
manage the pregnancies54, and the remaining five studies did not report on this 
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issue46,49,55,57,64. Eleven studies provided data on the predictive accuracy of the 
CPR for a composite of adverse perinatal outcomes43,44,47,53,54,56-60,62, nine on 
admission to the NICU43-45,51,56,58-60,62,  seven on cesarean delivery for non-
reassuring fetal status43,45,50,58-60,62, six each on perinatal death45,52,55,56,58,60 and 
Apgar <7 at 5 minutes43,44,51,58,59,64, five each on neonatal acidosis50,51,59,62,64 and 
neonatal brain lesions45,48,52,55,63, four on neonatal morbidities other than brain 
lesions43,45,46,49, two on  SGA at birth43,59, and one on use of mechanical 
ventilation55. No study provided data on adverse neurodevelopmental outcomes.  
The risk of bias in each included study is shown in Figure 2. Eight studies 
(36%) fulfilled ≥5 criteria, whereas the remaining 14 studies (64%) had ≥2 
methodological flaws. The most common deficiencies were related to blinding of 
clinicians to the CPR results and inclusion of participants recruited into the study 
in the analyses.   
Predictive accuracy for adverse perinatal outcomes 
Summary ROC curves of the CPR for predicting adverse perinatal outcomes in 
pregnancies with suspected FGR are shown in Figure 3. The best predictive 
accuracy was for perinatal death and the worst was for neonatal acidosis, with 
areas under the summary ROC curves of 0.83 (95% CI, 0.74-0.92) and 0.57 
(95% CI, 0.51-0.63), respectively. Similar summary ROC curves were obtained 
for the prediction of any composite of adverse perinatal outcomes, cesarean 
delivery for non-reassuring fetal status, and admission to the NICU (areas under 
the summary ROC curves between 0.71 and 0.74). The sensitivity and specificity 
of the CPR ratio to predict adverse perinatal outcomes in suspected fetal growth 
restriction in the individual studies are shown in Figure S1. 
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Table 2 presents the pooled estimates of the predictive accuracy of the 
CPR for adverse perinatal outcomes. Overall, the CPR showed a moderate-to-
high predictive ability for perinatal death with pooled sensitivity and specificity of 
93% and 76%, respectively, and summary positive and negative LRs of 3.9 and 
0.09, respectively (six studies, 1495 fetuses, 29 perinatal deaths). The CPR had 
a low predictive performance for any composite of adverse perinatal outcomes, 
cesarean delivery for non-reassuring fetal status, Apgar <7 at 5 minutes, 
admission to the NICU, neonatal acidosis, neonatal brain lesions, neonatal 
morbidities other than brain lesions, and use of mechanical ventilation with 
summary positive and negative LRs that varied between 1.1 and 2.5, and 0.3 
and 0.9, respectively. An abnormal CPR result had moderate accuracy for 
predicting SGA at birth (summary positive LR of 7.4; two studies, 554 fetuses). 
Based on all included studies, we estimated that fetuses with suspected growth 
restriction had a prevalence rate (pretest probability) of 25% for the composite of 
adverse perinatal outcomes, 2.0% for perinatal death, and 90% for SGA at birth 
(birthweight <10th percentile for GA). Then, based on estimated pretest 
probabilities and summary positive and negative LRs, we calculated that an 
abnormal CPR result would increase the pretest probability of the composite of 
adverse perinatal outcomes, perinatal death, and SGA at birth from 25% to 45%, 
2% to 7.4%, and 90% to 98.5%, respectively, whereas a normal CPR result 
would decrease the pretest probability to 17%, 0.2%, and 84%, respectively.     
Visual assessment of both forest plots (Figure S1) and summary ROC 
curves (Figure 3) suggested substantial between-study heterogeneity, mainly for 
perinatal death, any composite of adverse perinatal outcomes, cesarean delivery 
for non-reassuring fetal status, and admission to the NICU. Meta-regression 
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analyses showed that none of the prespecified covariates explained the 
heterogeneity (Table S1). Sensitivity analyses revealed that pooled predictive 
accuracy estimates obtained from studies with low risk of bias in ≥5 domains did 
not differ significantly from those obtained in the overall analysis (data not 
shown). The funnel plot of the meta-analysis that included at least ten studies 
showed no significant asymmetry (P = 0.19, by Deeks’ test). 
Subgroup analyses 
Subgroup analyses of the accuracy of the CPR to predict any composite of 
adverse perinatal outcomes are depicted in Table 3. The CPR had a significantly 
higher predictive accuracy for any composite of adverse perinatal outcomes 
among pregnancies with suspected early-onset FGR than among those with 
suspected late-onset FGR. Moreover, the accuracy of the CPR for predicting any 
composite of adverse perinatal outcomes was lower when using a MCA-PI/UA-PI 
<5th percentile as the abnormal result and when the CPR results were used to 
manage pregnancies. There were no differences in the predictive ability of the 
CPR between studies in which the interval from CPR to delivery was ≤7 days or 
>days, and between studies using an EFW <10th percentile for GA as definition 
of suspected FGR and that using an EFW <10th percentile for GA and abnormal 
UA Doppler as definition of suspected FGR.  
DISCUSSION 
Main findings 
The results of this systematic review indicate that the CPR had a moderate-to-
high predictive accuracy for perinatal death, the most important outcome 
measure in relation with utero-placental insufficiency in suspected FGR. In 
particular, a normal CPR result had high accuracy to identify which fetuses with 
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suspected growth restriction are at low risk of dying in the perinatal period, 
decreasing the pretest probability of perinatal death from 2% to 0.2%. Overall, 
the CPR had a low predictive accuracy for the other adverse perinatal outcomes 
considered, several of which are less correlated with utero-placental insufficiency 
in suspected FGR. Notwithstanding, the presence of an abnormal CPR result 
increased the pretest probability of having an adverse perinatal outcome from 
25% to 45%. In addition, subgroup analyses suggest that the predictive accuracy 
of the CPR is higher in pregnancies with suspected early-onset FGR and when a 
MCA-PI/UA-PI ≤1.08 or a MCA-RI/UA-RI <1 or <1.05 is used as the definition of 
an abnormal CPR.  
Previously, it has been suggested that the CPR is a stronger predictor of 
adverse perinatal outcomes in suspected late-onset FGR than suspected early-
onset FGR23,25-27. Unexpectedly, our subgroup analysis showed the opposite: a 
higher predictive accuracy for adverse perinatal outcomes in pregnancies with 
suspected early-onset FGR. Usually, suspected late-onset FGR is characterized 
by abnormal Doppler indices involving the MCA, with a normal or minimally 
elevated resistance of the UA22. In contrast, suspected early-onset FGR is 
characterized by abnormal Doppler indices of both the UA and MCA22.
Abnormality in both vessels included in the calculation of the CPR, in particular 
high values of UA indices, could explain the better predictive accuracy of the 
CPR in suspected early-onset FGR in comparison with suspected late-onset 
FGR in which there are abnormal indices in only one vessel.  
It was noteworthy that no included study provided data to assess the 
predictive ability of the CPR for adverse neurodevelopmental outcomes in 
pregnancies with suspected FGR. A secondary analysis of the TRUFFLE study65
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reported that the CPR was not associated with neurodevelopmental impairment 
at 2 years’ corrected age in fetuses with suspected early-onset growth 
restriction66. Two studies reported similar results for a decreased MCA-PI in 
suspected FGR67,68. A systematic review reported that SGA or growth-restricted 
fetuses with cerebral redistribution may be at higher risk of adverse 
neurodevelopmental outcomes69. However, none of the studies included in this 
review used the CPR for defining cerebral redistribution.     
Strengths and limitations 
The reliability and robustness of our systematic review are supported by the: (1) 
adherence to guidelines for the conduct and reporting of systematic reviews of 
predictive test accuracy; (2) use of a prospective protocol designed to address a 
highly specific research question; (3) comprehensive literature search without 
language restrictions; (4) inclusion of a relatively large number of studies, mostly 
published in recent years; (5) strict study quality assessment; (6) quantitative 
synthesis of the evidence; (7) use of contemporary statistical methods to obtain 
summary measures of predictive accuracy including subgroup and sensitivity 
analyses; and (8) exploration of potential sources of heterogeneity.  
Limitations include the lack of blinding of the CPR results or omission of 
information on this subject in approximately two-thirds of the included studies. 
Although most studies reported that the CPR results were not used to manage 
pregnancies with suspected FGR, it is possible that women with abnormal CPR 
results were followed-up more closely or received interventions, which could 
have introduced bias in the assessment of the test’s predictive accuracy. 
However, sensitivity analyses that were restricted to studies at low risk of 
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blinding bias showed no significant differences in the results obtained with 
overall meta-analyses.  
There were considerable differences among studies in the definition of 
suspected FGR and Doppler indices/cut-off values used for defining an abnormal 
CPR, which limit the generalisability of our findings. Moreover, prespecified 
variables did not explain substantial heterogeneity and therefore, pooled 
estimates of predictive accuracy should be interpreted cautiously. Finally, the 
statistical power of some of our meta-analyses was limited by the small number 
of studies within each subgroup and the relatively small number of outcome 
events in some included studies.  
Interpretation in the light of previous systematic reviews 
We identified three systematic reviews on the predictive accuracy of the CPR for 
adverse perinatal outcomes70-72. Nassr et al 70 included seven studies, and 
reported that an abnormal CPR in pregnancies at high risk for FGR or with 
diagnosis of FGR increased the risk for adverse perinatal outcomes. Summary 
ROC curves showed that the CPR had a better predictive accuracy for neonatal 
complications and NICU admission. Dunn et al 71 reported that the CPR was 
predictive of cesarean section for intrapartum fetal compromise, SGA, and NICU 
admission in pregnancies at term. These reviews did not report pooled estimates 
of predictive accuracy. Finally, Vollgraff Heidweiller-Schreurs et al.72 assessed 
the accuracy of the CPR to predict adverse perinatal outcomes in singleton 
pregnancies of all risk profiles. The CPR was significantly superior to UA and 
MCA Doppler in predicting a composite of adverse perinatal outcomes and 
emergency delivery for fetal distress. No differences were found between the 
CPR and either UA Doppler or MCA Doppler in the prediction of perinatal death, 
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low Apgar score, or NICU admission. Overall, our estimates of the predictive 
accuracy of the CPR for adverse perinatal outcomes among pregnancies with 
suspected FGR were lower than those reported in this review among 
pregnancies of all risk profiles.  
The CPR has been hypothesized to be a more accurate test for predicting 
adverse perinatal outcomes than its individual components UA and MCA 
Doppler. When comparing the estimates obtained in our study with those 
reported in two meta-analyses that assessed the accuracy of UA Doppler73 and 
MCA Doppler74 to predict adverse perinatal outcomes in high-risk pregnancies, 
the CPR had better predictive accuracy for perinatal death (summary positive 
and negative LRs of 3.9 and 0.09, respectively) than both UA Doppler (summary 
positive and negative LRs of 2.5 and 0.3, respectively) and MCA Doppler 
(summary positive and negative LRs of 1.4 and 0.5, respectively). In general, the 
predictive accuracy of the CPR for other adverse perinatal outcomes appeared to 
be comparable to those of UA Doppler and MCA Doppler.    
Conclusions
The CPR appears to be useful in predicting perinatal death in pregnancies with 
suspected FGR. Nevertheless, before incorporating the CPR into the routine 
clinical management of suspected FGR, randomized controlled trials –ideally 
blinded- should assess whether the use of the CPR reduces perinatal death or 
other adverse perinatal outcomes. Studies are required to assess the predictive 
accuracy of the CPR for adverse neurodevelopmental outcomes in fetuses with 
antenatally suspected growth restriction.    
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